Characterization on the oncogenic effect of the missense mutations of p53 via machine learning.


Journal

Briefings in bioinformatics
ISSN: 1477-4054
Titre abrégé: Brief Bioinform
Pays: England
ID NLM: 100912837

Informations de publication

Date de publication:
22 Nov 2023
Historique:
received: 14 06 2023
revised: 13 10 2023
accepted: 05 11 2023
medline: 30 11 2023
pubmed: 29 11 2023
entrez: 29 11 2023
Statut: ppublish

Résumé

Dysfunctions caused by missense mutations in the tumour suppressor p53 have been extensively shown to be a leading driver of many cancers. Unfortunately, it is time-consuming and labour-intensive to experimentally elucidate the effects of all possible missense variants. Recent works presented a comprehensive dataset and machine learning model to predict the functional outcome of mutations in p53. Despite the well-established dataset and precise predictions, this tool was trained on a complicated model with limited predictions on p53 mutations. In this work, we first used computational biophysical tools to investigate the functional consequences of missense mutations in p53, informing a bias of deleterious mutations with destabilizing effects. Combining these insights with experimental assays, we present two interpretable machine learning models leveraging both experimental assays and in silico biophysical measurements to accurately predict the functional consequences on p53 and validate their robustness on clinical data. Our final model based on nine features obtained comparable predictive performance with the state-of-the-art p53 specific method and outperformed other generalized, widely used predictors. Interpreting our models revealed that information on residue p53 activity, polar atom distances and changes in p53 stability were instrumental in the decisions, consistent with a bias of the properties of deleterious mutations. Our predictions have been computed for all possible missense mutations in p53, offering clinical diagnostic utility, which is crucial for patient monitoring and the development of personalized cancer treatment.

Identifiants

pubmed: 38018912
pii: 7453441
doi: 10.1093/bib/bbad428
pmc: PMC10685404
pii:
doi:

Substances chimiques

Tumor Suppressor Protein p53 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Health and Medical Research Council
ID : GNT1174405
Organisme : Victorian Government's Operational Infrastructure Support Program

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press.

Références

Nucleic Acids Res. 2020 Jul 2;48(W1):W125-W131
pubmed: 32432715
Curr Protoc Hum Genet. 2013 Jan;Chapter 7:Unit7.20
pubmed: 23315928
J Comput Aided Mol Des. 2003 Nov;17(11):725-38
pubmed: 15072433
Brief Bioinform. 2022 Mar 10;23(2):
pubmed: 35043155
J Mol Evol. 1984-1985;21(2):112-25
pubmed: 6100188
Genes Dev. 1994 Nov 1;8(21):2540-51
pubmed: 7958916
Mol Cell Biol. 1994 Aug;14(8):5182-91
pubmed: 8035799
Curr Protoc Bioinformatics. 2016 Jun 20;54:5.6.1-5.6.37
pubmed: 27322406
Protein Eng. 2001 Mar;14(3):141-8
pubmed: 11342709
Cell Commun Signal. 2013 Apr 17;11(1):27
pubmed: 23594441
Nucleic Acids Res. 2018 Jul 2;46(W1):W350-W355
pubmed: 29718330
Elife. 2020 Dec 02;9:
pubmed: 33263541
Nat Mach Intell. 2020 Jan;2(1):56-67
pubmed: 32607472
Structure. 2018 Sep 4;26(9):1237-1250.e6
pubmed: 30057026
Bioinformatics. 2009 Jun 1;25(11):1422-3
pubmed: 19304878
Int J Mol Sci. 2021 Jan 09;22(2):
pubmed: 33435356
Sci Rep. 2018 Oct 18;8(1):15356
pubmed: 30337649
Annu Rev Biophys Biomol Struct. 2000;29:291-325
pubmed: 10940251
Hum Mutat. 2006 Jan;27(1):14-20
pubmed: 16278824
Science. 1996 Nov 8;274(5289):948-53
pubmed: 8875929
Hum Mutat. 2002 Jun;19(6):607-14
pubmed: 12007217
Cell Chem Biol. 2022 Sep 15;29(9):1381-1395.e13
pubmed: 35948006
Genes Dev. 2003 Sep 15;17(18):2233-8
pubmed: 12952892
J Mol Biol. 1993 Dec 5;234(3):779-815
pubmed: 8254673
Nucleic Acids Res. 2017 Jul 3;45(W1):W229-W235
pubmed: 28525590
Cell. 1992 Nov 13;71(4):587-97
pubmed: 1423616
Hum Mutat. 2021 Mar;42(3):223-236
pubmed: 33300245
Mol Cell. 2015 Mar 19;57(6):1034-1046
pubmed: 25794615
Comput Struct Biotechnol J. 2021 Sep 16;19:5381-5391
pubmed: 34667533
Protein Sci. 2021 Jan;30(1):60-69
pubmed: 32881105
Bioinformatics. 2015 Aug 15;31(16):2745-7
pubmed: 25851949
Protein Sci. 1995 Dec;4(12):2517-25
pubmed: 8580842
Sci Rep. 2022 Jun 21;12(1):10458
pubmed: 35729312
Oncoimmunology. 2020 Mar 2;9(1):1731943
pubmed: 32158625
Nucleic Acids Res. 2017 Jul 3;45(W1):W241-W246
pubmed: 28383703
Life (Basel). 2022 Dec 22;13(1):
pubmed: 36675980
Brief Bioinform. 2022 Mar 10;23(2):
pubmed: 35189634
Nat Commun. 2021 Feb 12;12(1):986
pubmed: 33579943
Curr Biol. 2001 Oct 30;11(21):1722-7
pubmed: 11696333
Cold Spring Harb Perspect Med. 2017 Apr 3;7(4):
pubmed: 28270529
Sci Rep. 2020 Nov 23;10(1):20368
pubmed: 33230179
Science. 2023 Sep 22;381(6664):eadg7492
pubmed: 37733863
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Nucleic Acids Res. 2019 Jul 2;47(W1):W338-W344
pubmed: 31114883
Sci Rep. 2020 Oct 22;10(1):18120
pubmed: 33093532
Nature. 2010 Apr 15;464(7291):993-8
pubmed: 20393554
Nucleic Acids Res. 2021 Jul 2;49(W1):W438-W445
pubmed: 34050760
Nucleic Acids Res. 2022 Jan 7;50(D1):D20-D26
pubmed: 34850941
J Mol Biol. 2001 Mar 23;307(2):721-35
pubmed: 11254392
Proteins. 2001 Feb 15;42(3):422-31
pubmed: 11151013
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Proc Natl Acad Sci U S A. 2012 May 1;109(18):7013-8
pubmed: 22509031
BMC Cancer. 2021 Sep 16;21(1):1035
pubmed: 34530752
Science. 1994 Jul 15;265(5170):346-55
pubmed: 8023157
Genome Biol. 2023 Aug 7;24(1):182
pubmed: 37550700
Nucleic Acids Res. 2015 Jul 1;43(W1):W395-400
pubmed: 25883149
Hum Mutat. 2003 Mar;21(3):176-81
pubmed: 12619103
J Mol Biol. 2022 May 15;434(9):167552
pubmed: 35341741
Science. 2001 Oct 19;294(5542):591-5
pubmed: 11557844
J Biol Chem. 2010 Jul 16;285(29):22473-83
pubmed: 20404322
Hum Mutat. 2007 Jun;28(6):622-9
pubmed: 17311302
EMBO J. 1995 Feb 1;14(3):512-9
pubmed: 7859740
Am J Hum Genet. 2021 Dec 2;108(12):2389
pubmed: 34861178
Cell Death Differ. 2018 Jan;25(1):154-160
pubmed: 29099487
Free Radic Biol Med. 2021 Aug 20;172:298-311
pubmed: 34144191
Comput Struct Biotechnol J. 2021 May 21;19:3097-3109
pubmed: 34141133
Cell Cycle. 2016 Dec;15(23):3210-3219
pubmed: 27754743
Mol Cell. 2018 Jul 5;71(1):178-190.e8
pubmed: 29979965
Science. 2000 Mar 10;287(5459):1824-7
pubmed: 10710310
Nucleic Acids Res. 2011 Jan;39(Database issue):D411-9
pubmed: 21071423
Genome Res. 2001 May;11(5):863-74
pubmed: 11337480
Biopolymers. 1983 Dec;22(12):2577-637
pubmed: 6667333
J Med Genet. 2023 May;60(5):484-490
pubmed: 36180205
Bioinformatics. 2013 Nov 1;29(21):2722-8
pubmed: 23986568
Nat Genet. 2013 Oct;45(10):1113-20
pubmed: 24071849
Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
pubmed: 9254694
EBioMedicine. 2020 Aug;58:102905
pubmed: 32739866
Nature. 2013 Oct 17;502(7471):333-339
pubmed: 24132290
Science. 1991 Jul 5;253(5015):49-53
pubmed: 1905840
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W314-9
pubmed: 24829462
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14338-42
pubmed: 9405613
Nucleic Acids Res. 1999 Jan 1;27(1):368-9
pubmed: 9847231
Nat Genet. 2018 Oct;50(10):1381-1387
pubmed: 30224644
Genes Dev. 1993 Dec;7(12B):2556-64
pubmed: 8276238
J Mol Biol. 2017 Feb 3;429(3):365-371
pubmed: 27964945
Cell Syst. 2018 Jan 24;6(1):116-124.e3
pubmed: 29226803
BMC Genomics. 2015;16 Suppl 8:S1
pubmed: 26110438
Mol Cell. 2013 Jun 27;50(6):805-17
pubmed: 23747015
Science. 1995 Mar 10;267(5203):1498-502
pubmed: 7878469
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4054-9
pubmed: 17360476
Bioinformatics. 2014 Feb 01;30(3):335-42
pubmed: 24281696
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
Bioinformatics. 2021 Apr 1;36(22-23):5322-5329
pubmed: 33325500
Nucleic Acids Res. 2019 Jul 2;47(W1):W121-W126
pubmed: 31170280
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067
pubmed: 29165669
Nat Genet. 2023 Sep;55(9):1512-1522
pubmed: 37563329
J Pathol Transl Med. 2020 Sep;54(5):378-386
pubmed: 32601264
J Mol Diagn. 2015 May;17(3):251-64
pubmed: 25801821
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8424-9
pubmed: 12826609

Auteurs

Qisheng Pan (Q)

School of Chemistry and Molecular Bioscience, University of Queensland, Brisbane Queensland 4072, Australia.
Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne Victoria 3004, Australia.

Stephanie Portelli (S)

School of Chemistry and Molecular Bioscience, University of Queensland, Brisbane Queensland 4072, Australia.
Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne Victoria 3004, Australia.

Thanh Binh Nguyen (TB)

School of Chemistry and Molecular Bioscience, University of Queensland, Brisbane Queensland 4072, Australia.
Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne Victoria 3004, Australia.

David B Ascher (DB)

School of Chemistry and Molecular Bioscience, University of Queensland, Brisbane Queensland 4072, Australia.
Computational Biology and Clinical Informatics, Baker Heart and Diabetes Institute, Melbourne Victoria 3004, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH